Dr. Reddy’s Laboratories announced that its promoters have transferred a total of 17,17,26,540 equity shares, representing 20.58% of the company’s equity, to their respective private family trusts. The off-market transfer, effective September 17, 2025, is aimed at succession planning and streamlining family assets. There is no change in management control following the transaction.
Promoter Share Transfer
Dr. Reddy’s Laboratories has received notification from its promoters regarding the transfer of shares to their private family trusts. The total number of shares transferred is 17,17,26,540, which constitutes 20.58% of the company’s equity. The transfer was executed through an off-market transaction on September 17, 2025.
Details of the Share Transfers
The share transfer was structured as follows:
- Satish Reddy Kallam transferred 7,56,30,620 equity shares (9.06%) to VSD Family Trust.
- G V Prasad transferred 9,60,95,920 equity shares (11.51%) to GVP Family Trust.
Rationale and Impact
The promoters stated that the transfer is part of a private family arrangement intended for succession planning and streamlining the management of family assets. The company has also confirmed that the share transfer does not result in any change in the management or control of Dr. Reddy’s Laboratories. Individual promoters, their immediate relatives and/or lineal descendants are the trustees and beneficiaries of the acquirer trusts.
Shareholding Pattern
Following the transfer, the shareholding pattern is as follows:
- VSD Family Trust now holds 7,56,30,620 shares (9.06%)
- GVP Family Trust now holds 9,60,95,920 shares (11.51%)
- Satish Reddy Kallam now directly holds 1,01,07,505 shares (1.21%)
- G V Prasad now directly holds 0 shares (0.00%)
The aggregate holding of the Promoter & Promoter group before and after the said transfer has remained the same.
Source: BSE
